Transcript
Dr. Neal Bhatia: Hi, I'm Dr. Neal Bhatia. I'm Chief Medical Editor of Practical Dermatology, and this is another installment of Dermatology Dialogues. I'm happy to be with Dr. Lourdes Perez-Chada from the great city of Boston. [Conversing in Spanish].
Dr. Lourdes Perez-Chada: [Conversing in Spanish].
Dr. Neal Bhatia: [Conversing in Spanish]. But I think we'll be better off in English. So tell us what you do at Harvard Medical School.
Dr. Lourdes Perez-Chada: Yes. So I am a dermatologist by training. I'm originally from Argentina, where I trained as a dermatologist, and now I work at Brigham and Women's Hospital as a clinical researcher. I also work as a co-director for a master's program in clinical research at Harvard Medical School.
Dr. Neal Bhatia: Oh, that's excellent. That's great. Well, I thought we could use your expertise to talk a little bit about psoriasis and psoriatic arthritis for the dermatologists, even though we also have rheumatologists who are going to listen with us. I really just wanted to see what you thought about some of the ways we're approaching psoriatic arthritis management and decision-making. Tell us what you think about the current landscape, where we all are with our treatment options and our approach. In dermatology especially, I think many of us would feel that in psoriasis patients, if we're not examining the joints, we're not fully doing our job, just like with rosacea, if we're not examining the eyes. Tell us some of your thoughts about where the role of the dermatologist fits.
Dr. Lourdes Perez-Chada: Sure. So I agree with the lines that you were going along, that it is part of the responsibility of the dermatologist nowadays to be mindful of the possibility of a patient with psoriasis having psoriatic arthritis. We know that patients who have psoriasis are at a higher risk of having psoriatic arthritis. About 30% of patients with psoriasis will evolve to have psoriatic arthritis. So it's important to keep in mind potential screening questions that should be used when we're facing a patient with psoriasis to identify whether the patient is at a higher risk than others and refer patients to rheumatology as needed. When we think about those questions, we should be asking about the presence of stiffness and joint pain and whether those have inflammatory characteristics or not. Is the patient describing a type of pain or stiffness that is more significant during the morning hours or after a period of inactivity? And is that pain or stiffness improved with exercise? Those are questions that could be leading us toward an inflammatory arthritis, in this case, psoriatic arthritis. There are, of course, validated screening tools such as the PEST that can be used in clinic. But if you don't have a screening tool handy, at least be aware of asking these questions: asking about heel pain, asking about back pain, lower back pain, and the characteristics of that pain. Those are also very useful when trying to screen these patients for the presence of arthritis. It's also relevant to know that there are certain phenotypes of psoriasis that could indicate that a patient may have psoriatic arthritis or is at a higher risk, such as the presence of scalp psoriasis and nail psoriasis. Nail psoriasis, particularly, is very associated with psoriatic arthritis, as is inverse psoriasis.
Dr. Neal Bhatia: That actually clears up a lot of potential misconceptions. I think that many of us in our careers were taught, or at least groomed to believe, that there were patients with higher BSA on the skin that correlated directly to psoriatic arthritis. And there were others that—
Dr. Lourdes Perez-Chada: Psoriasis severity is also another marker, a risk factor for the presence of psoriatic arthritis, for the development of psoriatic arthritis.
Dr. Neal Bhatia: Yeah. Well, that's good. And then we think, were there certain areas that were more of a predilection or at least concomitant with PsA, like posterior scalp? You mentioned the nails, which I think have a lot of good correlation to psoriatic arthritis and the joints. And then certain areas like supragluteal or the intertriginous areas, like you mentioned about intertriginous and inverse psoriasis and the axilla. Is there really any direct connection that's been proven outside of the nails?
Dr. Lourdes Perez-Chada: So the ones that are more consistently associated are nails and greater psoriasis severity, which I mentioned before. Then there are other characteristics that are not necessarily psoriasis-driven that are also very highly predictive, which are obesity and the family history of psoriatic arthritis. Then there are epidemiological studies that do show these higher-risk phenotypes that I mentioned before, such as scalp psoriasis, intragluteal psoriasis, and uveitis. And then there are some studies trying to see, in this prodromal phase of a patient with psoriasis transitioning into psoriatic arthritis, whether certain characteristics are predictive. There is some research in that space that showed that the presence of arthralgia or subclinical enthesitis or synovitis can also serve as high-risk characteristics for psoriatic arthritis. Related to the psoriasis phenotype itself, yes, it's nail psoriasis, intragluteal, genital, and the scalp.
Dr. Neal Bhatia: And that's always been another longstanding misconception among dermatologists, that if a patient has a high body surface area or their burden of psoriasis is more severe, they may be prone to just what are simple arthralgias that are not clearly having objective arthritic changes. Is there any value to disproving that?
Dr. Lourdes Perez-Chada: Yeah. So more severe skin disease is a risk factor for psoriatic arthritis. But as you just mentioned, not every arthralgia in a patient who has severe psoriasis is going to imply that the patient has psoriatic arthritis, right?
Dr. Neal Bhatia: Yeah.
Dr. Lourdes Perez-Chada: So we have to learn what the cues are to distinguish an inflammatory versus a non-inflammatory type of pain. For example, you want to rule out if a patient has osteoarthritis, which becomes very prevalent and common the more we age. I'm already starting to have signs, so I don't want to say very elderly people.
Dr. Neal Bhatia: No, that's very important. I think the other important thing to get through is this concept of progression, that somebody would start off saying they have low BSA or maybe they have random aches and pains, but they may think they have a progression to psoriatic arthritis. Is there such a thing that patients will progress to develop arthritis, or is that just a misconception?
Dr. Lourdes Perez-Chada: Yes. So we believe that there is this prodromal phase in which a patient has psoriasis initially, then they start presenting with certain pains, arthralgia, and eventually they develop legitimate psoriatic arthritis. There are some studies, particularly led by Lihi Eder in Toronto, in which they've shown that the presence of arthralgias in patients with psoriasis predicts the development of psoriatic arthritis later. But these are observational studies with imperfect assessments of that arthralgia. So they haven't necessarily been assessed by a rheumatologist to confirm at that point that it was not psoriatic arthritis in certain occasions. In some studies, yes, but not always. So the presence of arthralgia in a patient with psoriasis should make us think. Maybe at that time, that patient does not fulfill the criteria for psoriatic arthritis, but over time, they might transition into it.
Dr. Neal Bhatia: So that kind of builds into this concept of cycling.

